Daré Bioscience, Inc. (DARE)
2.09
+0.10
(+5.03%)
USD |
NASDAQ |
Dec 11, 16:00
2.26
+0.17
(+8.13%)
After-Hours: 06:50
Daré Bioscience Free Cash Flow: -17.15M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Omeros Corp. | -105.32M |
| GeoVax Labs, Inc. | -24.29M |
| Vistagen Therapeutics, Inc. | -53.96M |
| Editas Medicine, Inc. | -180.70M |
| Spero Therapeutics, Inc. | -27.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.4421M |
| Cash from Investing (Quarterly) | -0.1747M |
| Cash from Financing (Quarterly) | 18.65M |
| Free Cash Flow Per Share (Quarterly) | -0.0484 |
| Free Cash Flow to Equity (Quarterly) | -0.6807M |
| Free Cash Flow to Firm (Quarterly) | -0.4036M |
| Free Cash Flow Yield | -84.34% |